Q3 2025 Bioventus Inc Earnings Call Transcript

Nov 4, 2025 / 01:30 PM GMT

Transcript 10-Q8-K

Key Points

Positve

Bioventus Inc (BVS) reported an 8% organic revenue growth in the third quarter, demonstrating strong performance across its portfolio.
The company achieved a 13% increase in adjusted EBITDA, with a margin expansion of over 200 basis points.
Bioventus Inc (BVS) successfully launched new products in its pain treatments business, including peripheral nerve stimulation (PNS) and platelet-rich plasma (PRP) systems, which are expected to drive future growth.
The company's cash flow from operations nearly tripled compared to the same period last year, indicating strong financial health.
Bioventus Inc (BVS) maintained its full-year guidance, reflecting confidence in its strategic initiatives and market positioning.

Negative

The company faced an unplanned foreign exchange loss of nearly $50 million for the year, impacting financial results.
Revenue from the international segment decreased by 4% compared to the prior year, despite achieving 10% organic growth.
The divestiture of the advanced rehabilitation business led to a 29% decline in restorative therapies revenue.
There is ongoing price pressure in the HA market, particularly affecting the Gelson product line.
Bioventus Inc (BVS) continues to face challenges in scaling its commercial operations for new product launches, such as the PNS and PRP systems.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

BVS.OQ - Bioventus Inc
Q3 2025 Bioventus Inc Earnings Call
Nov 04, 2025 / 01:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good day and welcome to the Bioventis Inc. Third quarter 2025 earnings conference call. All participants will be in listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by 0. After today's presentation, there will be an opportunity. Ask questions to ask a question, you may have pressed, then 1 on your telephone keypad to withdraw your question, please press star, then 2. Please note this event is being recorded. I would now like to turn the comments over to Dave Crawford, Vice President investor relations. Please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]
-----------------------------------------------

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.